Ashley Keller
Overview
Explore the profile of Ashley Keller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
81
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Emerson S, Hart S, Sciarrillo C, Eden T, Godsey T, Smith H, et al.
Int J Environ Res Public Health
. 2025 Jan;
22(1).
PMID: 39857556
Normal weight obesity (NWO) is a body composition phenotype that is associated with increased cardiometabolic risk and is characterized by a normal weight body mass index but elevated body fat....
2.
Jain R, Peng G, Lee M, Keller A, Cosmich S, Reddy S, et al.
Chest
. 2024 Sep;
167(2):348-361.
PMID: 39343292
Background: Cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulators are available to the majority of people with CF in the United States; little is known about pregnancy outcomes with modulator...
3.
Holtrop M, Cosmich S, Lee M, Keller A, Jain R
Chest
. 2024 Jun;
166(5):951-962.
PMID: 38871282
Background: Historically, studies show that female patients with cystic fibrosis (CF) have worse pulmonary outcomes than male patients, including decreased life expectancy. It is unknown whether this disparity persists in...
4.
Abid S, Shaffer L, Bayat A, Lee M, Keller A, Jain R
J Cyst Fibros
. 2024 Apr;
23(5):874-877.
PMID: 38653651
Background: Levels of sulfated Dehydroepiandrosterone (DHEA-S) are unknown in people with Cystic Fibrosis (pwCF). DHEA-S is reported to have an inverse association with inflammation and warrants evaluation in pwCF. Methods:...
5.
Kazmerski T, Moy C, Aliaj E, Hudson J, Wright B, Poranski M, et al.
J Cyst Fibros
. 2024 Mar;
23(4):639-646.
PMID: 38485603
Background: To address sexual and reproductive health (SRH) concerns among people with cystic fibrosis(PwCF), the CF Foundation created the Sexual Health, Reproduction, and Gender Research (SHARING) Working Group. This report...
6.
Wang A, Lee M, Keller A, Jian S, Lowe K, Finklea J, et al.
J Cyst Fibros
. 2023 May;
23(1):91-98.
PMID: 37244841
Background: There is a well described sex-disparity in outcomes of individuals with cystic fibrosis (CF), with females faring worse than males. Given the dramatic improvement in overall health of people...
7.
Peng G, Taylor-Cousar J, Lee M, Keller A, West N, Kazmerski T, et al.
J Cyst Fibros
. 2023 Apr;
22(5):796-803.
PMID: 37029015
Introduction: Following availability of the highly effective cystic fibrosis (CF) transmembrane conductance regulator modulator, elexacaftor/tezacaftor/ivacaftor, there was a near doubling of pregnancies reported in the United States (US) in people...
8.
Abid S, Lee M, Rodich B, Hook J, Moreland J, Towler D, et al.
J Cyst Fibros
. 2022 Aug;
22(1):140-145.
PMID: 36041886
Background: As people with Cystic Fibrosis (CF) live longer, extra-pulmonary complications such as CF-related bone disease (CFBD) are becoming increasingly important. The etiology of CFBD is poorly understood but is...
9.
Jain R, Magaret A, Vu P, Vandalfsen J, Keller A, Wilson A, et al.
BMJ Open Respir Res
. 2022 Jun;
9(1).
PMID: 35710144
Introduction: Therapeutic advances have markedly increased life expectancy for those with cystic fibrosis (CF), resulting in a median predicted survival over 50 years. Consequently, people with CF (pwCF) are living...
10.
Shaffer L, McCormack E, Sawicki G, Keller A, Jain R
Ann Am Thorac Soc
. 2021 Sep;
19(3):504-506.
PMID: 34469707
No abstract available.